Intrinsiqs

Is Amgen Inc. overvalued?

Amgen Inc. (AMGN) looks overvalued — trading about 10% above its fair value.

Overvalued
Current price $358.33 Fair value $321.03
Price
$358.33
Fair value
$321.03
Current P/E
25.2
Normal P/E
22.6
Market cap
$193.39B
Dividend yield
2.9%
Return on equity
89.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AMGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.TMO Thermo Fisher Scientific Inc.